Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10674255rdf:typepubmed:Citationlld:pubmed
pubmed-article:10674255lifeskim:mentionsumls-concept:C0600433lld:lifeskim
pubmed-article:10674255lifeskim:mentionsumls-concept:C0584960lld:lifeskim
pubmed-article:10674255lifeskim:mentionsumls-concept:C0205484lld:lifeskim
pubmed-article:10674255pubmed:issue2lld:pubmed
pubmed-article:10674255pubmed:dateCreated2000-2-29lld:pubmed
pubmed-article:10674255pubmed:abstractTextAn increasing number of reports have focused on activated protein C resistance (APCR) as it has been shown not only to be the most common genetic factor predisposing patients to thromboembolic disease but the most common identifiable cause overall. More than 90 percent of the cases of APCR are caused by the factor V Leiden mutation, in which a guanine to adenine substitution in the factor V gene at nucleotide position 1691 results in a glutamine to arginine switch at position 506. Recent studies have also pointed to evidence of an association between APCR/factor V Leiden mutation and hypertensive disorders of pregnancy, first and second trimester miscarriage, placental infarction, and placental abruption.lld:pubmed
pubmed-article:10674255pubmed:languageenglld:pubmed
pubmed-article:10674255pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10674255pubmed:citationSubsetIMlld:pubmed
pubmed-article:10674255pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10674255pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10674255pubmed:statusMEDLINElld:pubmed
pubmed-article:10674255pubmed:monthFeblld:pubmed
pubmed-article:10674255pubmed:issn0029-7828lld:pubmed
pubmed-article:10674255pubmed:authorpubmed-author:GoodwinT MTMlld:pubmed
pubmed-article:10674255pubmed:authorpubmed-author:GhermanR BRBlld:pubmed
pubmed-article:10674255pubmed:issnTypePrintlld:pubmed
pubmed-article:10674255pubmed:volume55lld:pubmed
pubmed-article:10674255pubmed:ownerNLMlld:pubmed
pubmed-article:10674255pubmed:authorsCompleteYlld:pubmed
pubmed-article:10674255pubmed:pagination117-22lld:pubmed
pubmed-article:10674255pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:meshHeadingpubmed-meshheading:10674255...lld:pubmed
pubmed-article:10674255pubmed:year2000lld:pubmed
pubmed-article:10674255pubmed:articleTitleObstetric implications of activated protein C resistance and factor V Leiden mutation.lld:pubmed
pubmed-article:10674255pubmed:affiliationDivision of Maternal/Fetal Medicine, Portsmouth Naval Hospital, Virginia 23708-2197, USA. ghermtoo@aol.comlld:pubmed
pubmed-article:10674255pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10674255pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10674255lld:pubmed